Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine Wound Infiltration vs Caudal Block in Pediatric Inguinal Herniotomy
NCT07747038Completed
- Sponsor
- Fatima Memorial Hospital
- Start
- Jul 2025
- Primary completion
- Jul 2026
- Countries
- 1
01
Overview
Randomised, open-label trial of ropivacaine hydrochloride liposomal suspension injection in postoperative pain (2 arms), sponsored by Fatima Memorial Hospital. Primary endpoint: Postoperative Analgesic Requirement at 8 hours. Started Jul 2025; status: completed.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07747038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07747038.